STAT3 and cancer: Several in vitro and in vivo studies have validated the potent part played by STAT3 in precancerous physiology of the stomach, implying that STAT3 could be used as a predictive marker for diagnosis of GC, thus inhibiting STAT3 activity with several inhibitory molecules might help to prevent cancer (Khanna et al., 2015) (Table 2).